Germany - Respiratory System Medicine Use
Since 2014, Germany Respiratory System Medicine Use was down by 0.7% year on year. In 2019, the country was ranked number 20 among other countries in Respiratory System Medicine Use at 68.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany is overtaken by Luxembourg, which was ranked number 19 at 71.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Israel with 67.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Norway topped the ranking with 230.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 6% compared to 2018. Sweden, Finland and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +10.6% per year, while Slovakia witnessed the worst performance at -8.4% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 68.40 |
2018 | 69.30 |
2017 | 68.10 |
2016 | 70.60 |
2015 | 70.40 |
How does Germany rank in Respiratory System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Norway
|
230 | 2019 | +6.0 % | +3.3 % | View data | |
2 |
#2
Sweden
|
206 | 2019 | +6.1 % | +3.9 % | View data | |
19 |
#19
Luxembourg
|
72 | 2019 | -3.1 % | -0.7 % | View data | |
20 |
#20
Germany
|
68 | 2019 | -1.3 % | -0.7 % | View data | |
21 |
#21
Israel
|
67 | 2019 | +11.6 % | +6.0 % | View data |